These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 446735)

  • 1. Synthesis and isolation of a glucagon antagonist.
    Bregman MD; Hruby VJ
    FEBS Lett; 1979 May; 101(1):191-4. PubMed ID: 446735
    [No Abstract]   [Full Text] [Related]  

  • 2. Methylation of glucagon, characterization of the sulfonium derivative, and regeneration of the native covalent structure.
    Rothgeb TM; Jones BN; Hayes DF; Gurd RS
    Biochemistry; 1977 Dec; 16(26):5813-8. PubMed ID: 588556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [25-oxindolylalanine]glucagon and [27-methionine sulfoxide]glucagon: preparation, purification, and characterization.
    Coolican SA; Jones BN; England RD; Flanders KC; Condit JD; Gurd RS
    Biochemistry; 1982 Sep; 21(20):4974-81. PubMed ID: 7138842
    [No Abstract]   [Full Text] [Related]  

  • 4. Amphoptericin B has very different effects on the glucagon and fluoride-stimulated adenylate cyclase activities of rat liver plasma membranes.
    Dipple I; Houslay MD
    FEBS Lett; 1979 Oct; 106(1):21-4. PubMed ID: 499495
    [No Abstract]   [Full Text] [Related]  

  • 5. Glucagon structure and function. II. Increased activity of iodoglucagon.
    Bromer WW; Boucher ME; Patterson JM
    Biochem Biophys Res Commun; 1973 Jul; 53(1):134-9. PubMed ID: 4741542
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibitors of glucagon inactivation. Effect on glucagon--receptor interactions and glucagon-stimulated adenylate cyclase activity in liver cell membranes.
    Desbuquois B; Krug F; Cuatrecasas P
    Biochim Biophys Acta; 1974 Mar; 343(1):101-20. PubMed ID: 4364124
    [No Abstract]   [Full Text] [Related]  

  • 7. Properties of amidinated glucagons.
    Wright DE; Rodbell M
    Eur J Biochem; 1980 Oct; 111(1):11-6. PubMed ID: 7439177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of rat liver plasma membrane adenylate cyclase by a cytoplasmic protein factor.
    Doberska CA; Martin BR
    FEBS Lett; 1977 Oct; 82(2):273-7. PubMed ID: 913601
    [No Abstract]   [Full Text] [Related]  

  • 9. Activation by GTP of liver adenylate cyclase in the presence of high concentrations of ATP.
    Kimura N; Nakane K; Nagata N
    Biochem Biophys Res Commun; 1976 Jun; 70(4):1250-6. PubMed ID: 942443
    [No Abstract]   [Full Text] [Related]  

  • 10. Hormone receptors. I. Activation of rat liver plasma membrane adenylyl cyclase and fat cell lipolysis by agarose-glucagon.
    Johnson CB; Blecher M; Giorgio NA
    Biochem Biophys Res Commun; 1972 Feb; 46(3):1035-41. PubMed ID: 5012158
    [No Abstract]   [Full Text] [Related]  

  • 11. The stimulation of rat liver adenylate cyclase by prostaglandins E1 and E2.
    Yamashita L; Sweat FW
    Biochem Biophys Res Commun; 1976 May; 70(2):438-44. PubMed ID: 938500
    [No Abstract]   [Full Text] [Related]  

  • 12. Epinephrine-and glucagon-sensitive adenylate cyclases of rat liver during aging. Evidence for membrane instability associated with increased enzymatic activity.
    Kalish MI; Katz MS; Piñeyro MA; Gregerman RI
    Biochim Biophys Acta; 1977 Aug; 483(2):452-66. PubMed ID: 889839
    [No Abstract]   [Full Text] [Related]  

  • 13. Regulation of enzyme activity by glucagon: increased hormonal activity of iodinated glucagon.
    Fuller RW; Bromer WW; Snoddy HD; Baker JC
    Adv Enzyme Regul; 1975; 13():201-15. PubMed ID: 1975
    [No Abstract]   [Full Text] [Related]  

  • 14. Synthetic peptide antagonists of glucagon.
    Unson CG; Andreu D; Gurzenda EM; Merrifield RB
    Proc Natl Acad Sci U S A; 1987 Jun; 84(12):4083-7. PubMed ID: 3035568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carboxyl group modification in glucagon.
    Epand RM; Epand RF
    Biochim Biophys Acta; 1972 Nov; 285(1):176-80. PubMed ID: 4653335
    [No Abstract]   [Full Text] [Related]  

  • 16. Glucagon antagonists. Synthesis and inhibitory properties of Asp3-containing glucagon analogs.
    Andreu D; Merrifield RB
    Eur J Biochem; 1987 May; 164(3):585-90. PubMed ID: 3032623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of temperature on the activity of the adenylate cyclase system of liver plasma membranes.
    Pliego JA; Rubalcava B
    Biochem Biophys Res Commun; 1978 Feb; 80(3):609-15. PubMed ID: 629795
    [No Abstract]   [Full Text] [Related]  

  • 18. Solubilization of glucagon and epinephrine sensitive adenylate cyclase from rat liver plasma membranes.
    Ryan J; Storm DR
    Biochem Biophys Res Commun; 1974 Sep; 60(1):304-11. PubMed ID: 4418132
    [No Abstract]   [Full Text] [Related]  

  • 19. Inactivation of glucagon by plasma membranes of rat liver.
    Pohl SL; Krans HM; Birnbaumer L; Rodbell M
    J Biol Chem; 1972 Apr; 247(8):2295-301. PubMed ID: 4337268
    [No Abstract]   [Full Text] [Related]  

  • 20. Lipolytic and adenyl-cyclase-stimulating activity of N alpha-trinitrophenyl glucagon: comparison with other glucagon derivatives modified at the amino terminus.
    Jean-Baptiste E; Rizack MA; Epand RM
    Biosci Rep; 1982 Mar; 2(3):163-7. PubMed ID: 7066487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.